What You Should Know:
–Texas A&M Health and BurstIQ, a leader in advanced data management, today announced a partnership to leverage LifeGraph®, a graph-powered, end-to-end data management platform, to transform clinical research.
-This collaboration aims to enhance patient and researcher interactions while ensuring the highest standards of patient privacy and data rights.
Texas A&M Health: Advancing Healthcare through Innovation and Research
Texas A&M Health is a comprehensive health science center dedicated to advancing the future of healthcare and preparing the next generation of health professionals. It encompasses five schools:
– the School of Medicine
– the School of Nursing
– the Rangel School of Pharmacy
– the School of Public Health
– the School of Dentistry.
With a mission to improve the health and well-being of individuals and communities, Texas A&M Health emphasizes transformational education, innovative research, and impactful service.
The Institute of Biosciences & Technology, a premier research institute within Texas A&M Health, is located in the Texas Medical Center in Houston. It focuses on cutting-edge research in areas such as precision medicine, genomics, and biotechnology. The institute aims to translate scientific discoveries into real-world applications to improve health outcomes, fostering collaboration among scientists, clinicians, and industry partners to drive innovation and address critical health challenges.
LifeGraph is set to revolutionize Texas A&M Health’s PROVENANCE clinicogenomics registry programs by empowering all data stakeholders, including researchers, institutional stewards, and patients. This innovative solution ensures a secure and efficient data management system for all involved parties through:
– privacy-preserving techniques
– dynamic consent
– federated learning approaches.
Texas A&M Health leverages LifeGraph to create a comprehensive patient profile, combining:
– patient and population medical data
– genomics
– social determinants of health
– real-world data
– ambient data
– knowledge bases such as ClinGen and PharmGKB.
This holistic view empowers researchers with the contextualized data needed to discover new insights and build computational models for superior clinical decision support. The next-generation collaborative research network will provide external researchers and patients with the ability to access research studies that benefit them, enhancing informed decisions about participation in genomic research.
Ultimately, Texas A&M Health aims to:
– strengthen patient-researcher agency in data governance
– increase access and trust for underrepresented individuals
– accelerate the scale of clinicogenomic research
– enhance the implementation of precision medicine tools.
These efforts are poised to improve patient outcomes and offer a hopeful future for healthcare.
“LifeGraph provides a unique foundation for a modern, data-driven, and scalable approach to collaborative genomics research,” said Rick Silva, PhD, Executive Director of Clinical, Translational, and Industry Collaborations at Texas A&M Health’s Institute of Biosciences and Technology, Center for Precision and Genomic Medicine. “By securely linking clinical and non-clinical data in knowledge graphs and allowing patients to make informed decisions about participating in clinical research across time and the patient journey, we can better support patients, institutional data stewards, and enable researchers to derive more value from data. Now we can harness the power of real-world data to transform clinicogenomics research.”
